Horse vaccine from Boehringer Ingelheim as an aid in the prevention of disease caused by Eastern and Western encephalomyelitis and tetanus, as an aid in the prevention of viremia and mortality, as an aid in the reduction of severity of clinical disease caused by West Nile Virus, as an aid in the reduction of respiratory disease caused by equine herpes virus types 1 and 4 (EHV-1 and EHV-4), and as an aid in the reduction of respiratory disease and shedding caused by A2 equine influenza virus.
For vaccination of healthy horses 4 months of age or older. Duration of immunity against equine influenza is at least 6 months, and against West Nile Virus is at least 12 months.
Dosage: 1 ml IM, repeat in 3-4 weeks. Revaccinate annually.
Anaphylactoid reactions may occur. Antidote: Epinephrine.
U.S. Lic. No. 124.
